The MDSCs inhibit the antitumor immunity via various mechanisms including the crosstalk with other immunosuppressive cell types such as regulatory T cells (Tregs), M2 differentiated tumor-associated macrophages (TAMs) and T helper 2 (Th2) differentiated CD4+ T cells (5, 21–24). Here, CD4 is linked to neoplasm.